China ADR Privatizations: The Challenges of Getting the Best Deal
The stellar performance of China’s stock markets over the past twelve months (Shanghai +121%, Shenzhen +161%, and Hong Kong +17%) has led to a...
603 Views
Quiddity Leaderboard ChiNext & ChiNext 50 Jun26: Expected ADDs/DELs Can Change; US$1bn+ One-Way
We expect there to be US$899mn and US$216mn one-way flows for the ChiNext and ChiNext 50 in June 2026. Some names have double impacts.
264 Views
Opening of E-commerce Channel to Change China's Drug Market
Numerous press outlets report that China’s Food & Drug Administration (CFDA) will release regulations permitting online sales of...
602 Views
Pre-IPO Chengdu Olymvax Biopharmaceuticals (A/H Lising) - Low Profitability Is a Pain Point
​Olymvax faces profit challenges due to low "gold content" in profits.Controlling shareholders’ reduction in holdings reflect their lack of...
275 Views
Quiddity Leaderboard ChiNext & ChiNext 50 Jun26: Some Changes to Expectations
We see one-way flows of US$1.2bn and US$341mn for the ChiNext index and ChiNext 50 index respectively. Some names have multiple days of volume to...
316 Views